Budesonide EP Impurity I
Product Description
CAT No.
ALN-B022010
CAS No.
113930-13-5
Mol. F.
C25H34O7
Mol. Wt.
446.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 11β,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16α-yl butanoate (as per EP)
Smiles : CCCC(O[C@]1([H])C[C@@]2([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C[C@]2(C)[C@@]1(O)C(CO)=O)=O)=O
Inchi : InChI=1S/C25H32O5/c1-4-5-22-29-21-13-19-17-7-6-15-12-16(27)8-10-23(15,2)18(17)9-11-24(19,3)25(21,30-22)20(28)14-26/h8-10,12,17,19,21-22,26H,4-7,11,13-14H2,1-3H3/t17-,19+,21-,22-,23+,24+,25-/m1/s1
Synonym : 16α-Butyloxy Prednisolone ; 16α-Hydroxyprednisolone 16-butyrate
Technical Data
Reference
A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers
By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852
Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC
By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6
Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy
By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461
RFQ